MENU
+Compare
SAVA
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$2.23
Change
+$0.03 (+1.36%)
Capitalization
107.73M

SAVA Cassava Sciences Forecast, Technical & Fundamental Analysis

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease... Show more

SAVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SAVA with price predictions
Dec 24, 2025

SAVA in downward trend: price dove below 50-day moving average on November 28, 2025

SAVA moved below its 50-day moving average on November 28, 2025 date and that indicates a change from an upward trend to a downward trend. In of 42 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SAVA as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SAVA turned negative on December 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SAVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SAVA entered a downward trend on December 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SAVA's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SAVA advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

SAVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.321) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (311.015).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SAVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SAVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SAVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SAVA is expected to report earnings to fall 52.63% to -27 cents per share on March 03

Cassava Sciences SAVA Stock Earnings Reports
Q4'25
Est.
$-0.27
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.54
Q1'24
Beat
by $0.03
The last earnings report on March 03 showed earnings per share of -56 cents, missing the estimate of -47 cents. With 416.42K shares outstanding, the current market capitalization sits at 107.73M.
A.I.Advisor
published Dividends

SAVA paid dividends on December 24, 2012

Cassava Sciences SAVA Stock Dividends
А dividend of $0.75 per share was paid with a record date of December 24, 2012, and an ex-dividend date of December 13, 2012. Read more...
A.I. Advisor
published General Information

General Information

a developer of novel drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
6801 N. Capital of Texas Highway
Phone
+1 512 501-2444
Employees
29
Web
https://www.cassavasciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCGCF0.110.01
+5.63%
ROSCAN GOLD CORP.
CSYJY3.23N/A
N/A
CSE Global Ltd
MIESY41.10N/A
N/A
Mitsui E&S Co Ltd.
MONRF68.00N/A
N/A
Moncler S.P.A.
DRCR0.04-0.01
-12.16%
Dear Cashmere Holding Co.

SAVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SAVA has been loosely correlated with RXRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SAVA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAVA
1D Price
Change %
SAVA100%
+1.36%
RXRX - SAVA
39%
Loosely correlated
+0.92%
BEAM - SAVA
39%
Loosely correlated
+1.33%
CRSP - SAVA
37%
Loosely correlated
+0.44%
SYRE - SAVA
36%
Loosely correlated
-0.54%
KURA - SAVA
35%
Loosely correlated
+2.50%
More